Assessment of saliva as a non-invasive and reliable complement to nasopharyngeal swabs for COVID-19 diagnosis
Journal of Laboratory Physicians · 19.08.2026 · 1-8
DOI: 10.25259/jlp_89_2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Laboratory Physicians, online erschienen am 19.08.2026. Verfasst von Anindita Datta und 9 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Objectives
Nasopharyngeal/oropharyngeal (NP/OP) swabs, the gold standard for COVID-19 diagnosis, pose challenges including patient discomfort, need for trained personnel, and biosafety risks. This study evaluated the diagnostic performance of saliva as a less invasive alternative compared to the gold standard. Materials and Methods: Paired NP/OP and saliva samples were collected from 515 suspected COVID-19 patients. NP/OP swabs underwent standard RNA extraction and reverse transcription-polymerase chain reaction (RTPCR). Saliva samples were analyzed by RT-PCR, either directly (saliva-direct [SD]) or after RNA extraction (saliva-RNA [SR]). A subset of discordant samples (saliva-positive, NP/OP-negative), with cycle threshold values ≤32, was investigated using Nanopore sequencing. Statistical analysis: Sensitivity, specificity, and Cohen’s Kappa were used to assess agreement between NP/OP and each saliva protocol. McNemar’s test compared detection rates between methods, and paired t-tests/Wilcoxon signed-rank tests compared Ct values between NP/OP and saliva-RNA assays.
Results
Of 515 participants, NP/OP swabs yielded 114 positives (reference standard), SR yielded 117, and SD yielded 147. SR sensitivity/specificity was 61.4%/88.28% compared to NP/OP. SD sensitivity/specificity was 70.17%/83.29%. Cohen’s Kappa was 0.50 (0.399–0.581) for SR and 0.48 (0.395–0.569) for SD. 16.69% of saliva-positive samples were NP/OP negative. Nanopore sequencing confirmed severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) RNA in 78.26% of discordant saliva samples.
Conclusions
Saliva shows promise as a complementary, adjunct specimen for COVID-19 diagnosis, potentially enhancing case detection. While sensitivity was lower than NP/OP, the direct saliva method demonstrated improved detection. The simplified collection and reduced biosafety risks associated with saliva offer significant advantages.
Zitieren
APA
Datta, A., Malhotra, A. G., Kale, D., Namdeo, D., Yadav, A. K., Vishwakarma, S. P., Singh, J., Nema, S., Joshi, R., & Biswas, D. (2026). Assessment of saliva as a non-invasive and reliable complement to nasopharyngeal swabs for COVID-19 diagnosis. Journal of Laboratory Physicians, 0, 1-8. https://doi.org/10.25259/jlp_89_2026
Vancouver
Datta A, Malhotra AG, Kale D, Namdeo D, Yadav AK, Vishwakarma SP, et al. Assessment of saliva as a non-invasive and reliable complement to nasopharyngeal swabs for COVID-19 diagnosis. Journal of Laboratory Physicians. 2026;0:1-8. doi:10.25259/jlp_89_2026
BibTeX
@article{Datta2026,
author = {Datta, Anindita and Malhotra, Anvita Gupta and Kale, Dipesh and Namdeo, Divya and Yadav, Ashvini Kumar and Vishwakarma, Satya Prakash and Singh, Jitendra and Nema, Shashwati and Joshi, Rajnish and Biswas, Debasis},
title = {Assessment of saliva as a non-invasive and reliable complement to nasopharyngeal swabs for COVID-19 diagnosis},
journal = {Journal of Laboratory Physicians},
year = {2026},
volume = {0},
pages = {1--8},
doi = {10.25259/jlp_89_2026}
}
EUVIMED